.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,946,292

« Back to Dashboard

Claims for Patent: 8,946,292

Title:Formulations of low dose diclofenac and beta-cyclodextrin
Abstract: The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 75 mg, e.g., from about 18.75 mg to about 37.5 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.
Inventor(s): Wright; Curtis (Rockport, MA), Carr; Daniel B. (Chestnut Hill, MA), Mermelstein; Fred H. (Newtown, MA)
Assignee: Javelin Pharmaceuticals, Inc. (Lake Forest, IL)
Application Number:13/106,697
Patent Claims: 1. A method of providing analgesia to a subject in need thereof, which method comprises parenterally administering to the subject a pharmaceutical composition, wherein the composition comprises: (a) from about 18.75 mg to about 37.5 mg of a diclofenac compound; and (b) a beta-cyclodextrin compound; wherein the dosage of the diclofenac compound is less than about 1.3 mg/kg per day; and wherein the method achieves at least about 82% of maximum observable total pain relief assessed by a Visual Analog Scale.

2. The method of claim 1, wherein the diclofenac compound is diclofenac sodium.

3. The method of claim 1, wherein the pharmaceutical composition is administered intravenously.

4. The method of claim 1, wherein the dose of the diclofenac compound is 18.75 mg (+/-20%).

5. The method of claim 1, wherein the dose diclofenac compound is 37.5 mg (+/-20%).
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc